APO Research
Talk to an analyst

APO RESEARCH · REPORT

Molecular Diagnostics Tests & Reagents

Compare research editions
View pricing & licenses

Selected research

Industry Research

Molecular Diagnostics Tests & Reagents Industry Research Report 2026

19 December 2025145 pages

Choose your research edition.

Industry ResearchMolecular Diagnostics Tests & Reagents Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Molecular Diagnostics Tests & Reagents Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Molecular Diagnostics Tests & Reagents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Molecular Diagnostics Tests & Reagents Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Molecular Diagnostics Tests & Reagents Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Molecular Diagnostics Tests & Reagents market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Molecular Diagnostics Tests & Reagents market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Molecular Diagnostics Tests & Reagents market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Molecular Diagnostics Tests & Reagents market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Molecular Diagnostics Tests & Reagents include Abbott Laboratories, Shanghai Kehua Bio-engineering, Johnson and Johnson, Merck Millipore, Beijing Leadman Biochemistry, Thermo Scientific, Sysmex Corporation, Siemens Healthcare and Roche Diagnostics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Molecular Diagnostics Tests & Reagents market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Molecular Diagnostics Tests & Reagents.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Molecular Diagnostics Tests & Reagents Market by Company

Abbott Laboratories

Shanghai Kehua Bio-engineering

Johnson and Johnson

Merck Millipore

Beijing Leadman Biochemistry

Thermo Scientific

Sysmex Corporation

Siemens Healthcare

Roche Diagnostics

Ortho Clinical Diagnostics

Mindray

Danaher Corporation

DAAN Gene

Cobas

Caprion

BioSino Bio-technology

Bio-Rad Laboratories

Biomerieux

Becton Dickinson

Beckman Coulter Inc

Aptiv Solution

Molecular Diagnostics Tests & Reagents Segment by Type

Professional Diagnostic

Diabetes Monitoring

Molecular Diagnostic

Molecular Diagnostics Tests & Reagents Segment by Application

HIV

Infectious Diseases

Diabetes

Cardiology

Oncology

Other

Molecular Diagnostics Tests & Reagents Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Diagnostics Tests & Reagents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Molecular Diagnostics Tests & Reagents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Diagnostics Tests & Reagents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Molecular Diagnostics Tests & Reagents companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Molecular Diagnostics Tests & Reagents Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Molecular Diagnostics Tests & Reagents Revenue Market Share by Type (2021-2026) Table 7. Global Molecular Diagnostics Tests & Reagents Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Molecular Diagnostics Tests & Reagents Revenue Market Share by Type (2027-2032) Table 9. Global Molecular Diagnostics Tests & Reagents Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Molecular Diagnostics Tests & Reagents Revenue Market Share by Application (2021-2026) Table 11. Global Molecular Diagnostics Tests & Reagents Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Molecular Diagnostics Tests & Reagents Revenue Market Share by Application (2027-2032) Table 13. Global Molecular Diagnostics Tests & Reagents Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Molecular Diagnostics Tests & Reagents Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Molecular Diagnostics Tests & Reagents Market Share by Region (2021-2026) Table 16. Global Molecular Diagnostics Tests & Reagents Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Molecular Diagnostics Tests & Reagents Market Share by Region (2027-2032) Table 18. Molecular Diagnostics Tests & Reagents Industry Trends Table 19. Molecular Diagnostics Tests & Reagents Industry Drivers Table 20. Molecular Diagnostics Tests & Reagents Industry Opportunities and Challenges Table 21. Molecular Diagnostics Tests & Reagents Market Restraints Table 22. Global Top Molecular Diagnostics Tests & Reagents Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Molecular Diagnostics Tests & Reagents Revenue Market Share by Players (2021-2026) Table 24. Global Molecular Diagnostics Tests & Reagents Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Molecular Diagnostics Tests & Reagents, Headquarters and Area Served Table 26. Global Molecular Diagnostics Tests & Reagents Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Molecular Diagnostics Tests & Reagents by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Molecular Diagnostics Tests & Reagents Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Molecular Diagnostics Tests & Reagents Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Molecular Diagnostics Tests & Reagents Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Molecular Diagnostics Tests & Reagents Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Molecular Diagnostics Tests & Reagents Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Molecular Diagnostics Tests & Reagents Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Molecular Diagnostics Tests & Reagents Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Molecular Diagnostics Tests & Reagents Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Molecular Diagnostics Tests & Reagents Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Molecular Diagnostics Tests & Reagents Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Molecular Diagnostics Tests & Reagents Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Molecular Diagnostics Tests & Reagents Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Molecular Diagnostics Tests & Reagents Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Molecular Diagnostics Tests & Reagents Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Molecular Diagnostics Tests & Reagents Market Size by Country (2027-2032) & (US$ Million) Table 45. Abbott Laboratories Company Information Table 46. Abbott Laboratories Business Overview Table 47. Abbott Laboratories Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026) & (US$ Million) Table 48. Abbott Laboratories Molecular Diagnostics Tests & Reagents Product Portfolio Table 49. Abbott Laboratories Recent Developments Table 50. Shanghai Kehua Bio-engineering Company Information Table 51. Shanghai Kehua Bio-engineering Business Overview Table 52. Shanghai Kehua Bio-engineering Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026) & (US$ Million) Table 53. Shanghai Kehua Bio-engineering Molecular Diagnostics Tests & Reagents Product Portfolio Table 54. Shanghai Kehua Bio-engineering Recent Developments Table 55. Johnson and Johnson Company Information Table 56. Johnson and Johnson Business Overview Table 57. Johnson and Johnson Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026) & (US$ Million) Table 58. Johnson and Johnson Molecular Diagnostics Tests & Reagents Product Portfolio Table 59. Johnson and Johnson Recent Developments Table 60. Merck Millipore Company Information Table 61. Merck Millipore Business Overview Table 62. Merck Millipore Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026) & (US$ Million) Table 63. Merck Millipore Molecular Diagnostics Tests & Reagents Product Portfolio Table 64. Merck Millipore Recent Developments Table 65. Beijing Leadman Biochemistry Company Information Table 66. Beijing Leadman Biochemistry Business Overview Table 67. Beijing Leadman Biochemistry Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026) & (US$ Million) Table 68. Beijing Leadman Biochemistry Molecular Diagnostics Tests & Reagents Product Portfolio Table 69. Beijing Leadman Biochemistry Recent Developments Table 70. Thermo Scientific Company Information Table 71. Thermo Scientific Business Overview Table 72. Thermo Scientific Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026) & (US$ Million) Table 73. Thermo Scientific Molecular Diagnostics Tests & Reagents Product Portfolio Table 74. Thermo Scientific Recent Developments Table 75. Sysmex Corporation Company Information Table 76. Sysmex Corporation Business Overview Table 77. Sysmex Corporation Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026) & (US$ Million) Table 78. Sysmex Corporation Molecular Diagnostics Tests & Reagents Product Portfolio Table 79. Sysmex Corporation Recent Developments Table 80. Siemens Healthcare Company Information Table 81. Siemens Healthcare Business Overview Table 82. Siemens Healthcare Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026) & (US$ Million) Table 83. Siemens Healthcare Molecular Diagnostics Tests & Reagents Product Portfolio Table 84. Siemens Healthcare Recent Developments Table 85. Roche Diagnostics Company Information Table 86. Roche Diagnostics Business Overview Table 87. Roche Diagnostics Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026) & (US$ Million) Table 88. Roche Diagnostics Molecular Diagnostics Tests & Reagents Product Portfolio Table 89. Roche Diagnostics Recent Developments Table 90. Ortho Clinical Diagnostics Company Information Table 91. Ortho Clinical Diagnostics Business Overview Table 92. Ortho Clinical Diagnostics Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026) & (US$ Million) Table 93. Ortho Clinical Diagnostics Molecular Diagnostics Tests & Reagents Product Portfolio Table 94. Ortho Clinical Diagnostics Recent Developments Table 95. Mindray Company Information Table 96. Mindray Business Overview Table 97. Mindray Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026) & (US$ Million) Table 98. Mindray Molecular Diagnostics Tests & Reagents Product Portfolio Table 99. Mindray Recent Developments Table 100. Danaher Corporation Company Information Table 101. Danaher Corporation Business Overview Table 102. Danaher Corporation Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026) & (US$ Million) Table 103. Danaher Corporation Molecular Diagnostics Tests & Reagents Product Portfolio Table 104. Danaher Corporation Recent Developments Table 105. DAAN Gene Company Information Table 106. DAAN Gene Business Overview Table 107. DAAN Gene Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026) & (US$ Million) Table 108. DAAN Gene Molecular Diagnostics Tests & Reagents Product Portfolio Table 109. DAAN Gene Recent Developments Table 110. Cobas Company Information Table 111. Cobas Business Overview Table 112. Cobas Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026) & (US$ Million) Table 113. Cobas Molecular Diagnostics Tests & Reagents Product Portfolio Table 114. Cobas Recent Developments Table 115. Caprion Company Information Table 116. Caprion Business Overview Table 117. Caprion Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026) & (US$ Million) Table 118. Caprion Molecular Diagnostics Tests & Reagents Product Portfolio Table 119. Caprion Recent Developments Table 120. BioSino Bio-technology Company Information Table 121. BioSino Bio-technology Business Overview Table 122. BioSino Bio-technology Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026) & (US$ Million) Table 123. BioSino Bio-technology Molecular Diagnostics Tests & Reagents Product Portfolio Table 124. BioSino Bio-technology Recent Developments Table 125. Bio-Rad Laboratories Company Information Table 126. Bio-Rad Laboratories Business Overview Table 127. Bio-Rad Laboratories Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026) & (US$ Million) Table 128. Bio-Rad Laboratories Molecular Diagnostics Tests & Reagents Product Portfolio Table 129. Bio-Rad Laboratories Recent Developments Table 130. Biomerieux Company Information Table 131. Biomerieux Business Overview Table 132. Biomerieux Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026) & (US$ Million) Table 133. Biomerieux Molecular Diagnostics Tests & Reagents Product Portfolio Table 134. Biomerieux Recent Developments Table 135. Becton Dickinson Company Information Table 136. Becton Dickinson Business Overview Table 137. Becton Dickinson Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026) & (US$ Million) Table 138. Becton Dickinson Molecular Diagnostics Tests & Reagents Product Portfolio Table 139. Becton Dickinson Recent Developments Table 140. Beckman Coulter Inc Company Information Table 141. Beckman Coulter Inc Business Overview Table 142. Beckman Coulter Inc Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026) & (US$ Million) Table 143. Beckman Coulter Inc Molecular Diagnostics Tests & Reagents Product Portfolio Table 144. Beckman Coulter Inc Recent Developments Table 145. Aptiv Solution Company Information Table 146. Aptiv Solution Business Overview Table 147. Aptiv Solution Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026) & (US$ Million) Table 148. Aptiv Solution Molecular Diagnostics Tests & Reagents Product Portfolio Table 149. Aptiv Solution Recent Developments Table 150. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Molecular Diagnostics Tests & Reagents Product Image Figure 5. Global Molecular Diagnostics Tests & Reagents Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Molecular Diagnostics Tests & Reagents Market Share by Type: 2025 VS 2032 Figure 7. Professional Diagnostic Product Figure 8. Diabetes Monitoring Product Figure 9. Molecular Diagnostic Product Figure 10. Global Molecular Diagnostics Tests & Reagents Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Molecular Diagnostics Tests & Reagents Market Share by Application: 2025 VS 2032 Figure 12. HIV Product Figure 13. Infectious Diseases Product Figure 14. Diabetes Product Figure 15. Cardiology Product Figure 16. Oncology Product Figure 17. Other Product Figure 18. Global Molecular Diagnostics Tests & Reagents Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 19. Global Molecular Diagnostics Tests & Reagents Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 20. Global Molecular Diagnostics Tests & Reagents Market Share by Region: 2025 VS 2032 Figure 21. Global Molecular Diagnostics Tests & Reagents Market Share by Players in 2025 Figure 22. Global Molecular Diagnostics Tests & Reagents Manufacturers Established Date Figure 23. Global Top 5 and 10 Molecular Diagnostics Tests & Reagents Players Market Share by Revenue in 2025 Figure 24. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. North America Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Molecular Diagnostics Tests & Reagents Market Share by Country (2021-2032) Figure 27. United States Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Canada Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Mexico Molecular Diagnostics Tests & Reagents Market Share by Country (2021-2032) Figure 30. Europe Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Molecular Diagnostics Tests & Reagents Market Share by Country (2021-2032) Figure 32. Germany Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. France Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. U.K. Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Italy Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Spain Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Russia Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Netherlands Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Nordic Countries Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Asia-Pacific Molecular Diagnostics Tests & Reagents Market Share by Country (2021-2032) Figure 42. China Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. Japan Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. South Korea Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. India Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. India Molecular Diagnostics Tests & Reagents Market Share by Country (2021-2032) Figure 47. Australia Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. China Taiwan Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. Southeast Asia Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. South America Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. South America Molecular Diagnostics Tests & Reagents Market Share by Country (2021-2032) Figure 52. Brazil Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Argentina Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Chile Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. Colombia Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 56. Peru Molecular Diagnostics Tests & Reagents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 57. Abbott Laboratories Revenue Growth Rate in Molecular Diagnostics Tests & Reagents Business (2021-2026) Figure 58. Shanghai Kehua Bio-engineering Revenue Growth Rate in Molecular Diagnostics Tests & Reagents Business (2021-2026) Figure 59. Johnson and Johnson Revenue Growth Rate in Molecular Diagnostics Tests & Reagents Business (2021-2026) Figure 60. Merck Millipore Revenue Growth Rate in Molecular Diagnostics Tests & Reagents Business (2021-2026) Figure 61. Beijing Leadman Biochemistry Revenue Growth Rate in Molecular Diagnostics Tests & Reagents Business (2021-2026) Figure 62. Thermo Scientific Revenue Growth Rate in Molecular Diagnostics Tests & Reagents Business (2021-2026) Figure 63. Sysmex Corporation Revenue Growth Rate in Molecular Diagnostics Tests & Reagents Business (2021-2026) Figure 64. Siemens Healthcare Revenue Growth Rate in Molecular Diagnostics Tests & Reagents Business (2021-2026) Figure 65. Roche Diagnostics Revenue Growth Rate in Molecular Diagnostics Tests & Reagents Business (2021-2026) Figure 66. Ortho Clinical Diagnostics Revenue Growth Rate in Molecular Diagnostics Tests & Reagents Business (2021-2026) Figure 67. Mindray Revenue Growth Rate in Molecular Diagnostics Tests & Reagents Business (2021-2026) Figure 68. Danaher Corporation Revenue Growth Rate in Molecular Diagnostics Tests & Reagents Business (2021-2026) Figure 69. DAAN Gene Revenue Growth Rate in Molecular Diagnostics Tests & Reagents Business (2021-2026) Figure 70. Cobas Revenue Growth Rate in Molecular Diagnostics Tests & Reagents Business (2021-2026) Figure 71. Caprion Revenue Growth Rate in Molecular Diagnostics Tests & Reagents Business (2021-2026) Figure 72. BioSino Bio-technology Revenue Growth Rate in Molecular Diagnostics Tests & Reagents Business (2021-2026) Figure 73. Bio-Rad Laboratories Revenue Growth Rate in Molecular Diagnostics Tests & Reagents Business (2021-2026) Figure 74. Biomerieux Revenue Growth Rate in Molecular Diagnostics Tests & Reagents Business (2021-2026) Figure 75. Becton Dickinson Revenue Growth Rate in Molecular Diagnostics Tests & Reagents Business (2021-2026) Figure 76. Beckman Coulter Inc Revenue Growth Rate in Molecular Diagnostics Tests & Reagents Business (2021-2026) Figure 77. Aptiv Solution Revenue Growth Rate in Molecular Diagnostics Tests & Reagents Business (2021-2026)

Scope & coverage.

Types
  • Professional Diagnostic
  • Diabetes Monitoring
  • Molecular Diagnostic
Applications
  • HIV
  • Infectious Diseases
  • Diabetes
  • Cardiology
  • Oncology
  • Other
Companies covered
  • Abbott Laboratories
  • Shanghai Kehua Bio-engineering
  • Johnson and Johnson
  • Merck Millipore
  • Beijing Leadman Biochemistry
  • Thermo Scientific
  • Sysmex Corporation
  • Siemens Healthcare
  • Roche Diagnostics
  • Ortho Clinical Diagnostics
  • Mindray
  • Danaher Corporation
  • DAAN Gene
  • Cobas
  • Caprion
  • BioSino Bio-technology
  • Bio-Rad Laboratories
  • Biomerieux
  • Becton Dickinson
  • Beckman Coulter Inc
  • Aptiv Solution

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Molecular Diagnostics Tests & Reagents by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Professional Diagnostic
  5. 2.2.3 Diabetes Monitoring
  6. 2.2.4 Molecular Diagnostic
  7. 2.3 Molecular Diagnostics Tests & Reagents by Application
  8. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  9. 2.3.2 HIV
  10. 2.3.3 Infectious Diseases
  11. 2.3.4 Diabetes
  12. 2.3.5 Cardiology
  13. 2.3.6 Oncology
  14. 2.3.7 Other
  15. 2.4 Assumptions and Limitations
3 Molecular Diagnostics Tests & Reagents Breakdown Data by Type
  1. 3.1 Global Molecular Diagnostics Tests & Reagents Historic Market Size by Type (2021-2026)
  2. 3.2 Global Molecular Diagnostics Tests & Reagents Forecasted Market Size by Type (2027-2032)
4 Molecular Diagnostics Tests & Reagents Breakdown Data by Application
  1. 4.1 Global Molecular Diagnostics Tests & Reagents Historic Market Size by Application (2021-2026)
  2. 4.2 Global Molecular Diagnostics Tests & Reagents Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Molecular Diagnostics Tests & Reagents Market Perspective (2021-2032)
  2. 5.2 Global Molecular Diagnostics Tests & Reagents Growth Trends by Region
  3. 5.2.1 Global Molecular Diagnostics Tests & Reagents Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Molecular Diagnostics Tests & Reagents Historic Market Size by Region (2021-2026)
  5. 5.2.3 Molecular Diagnostics Tests & Reagents Forecasted Market Size by Region (2027-2032)
  6. 5.3 Molecular Diagnostics Tests & Reagents Market Dynamics
  7. 5.3.1 Molecular Diagnostics Tests & Reagents Industry Trends
  8. 5.3.2 Molecular Diagnostics Tests & Reagents Market Drivers
  9. 5.3.3 Molecular Diagnostics Tests & Reagents Market Challenges
  10. 5.3.4 Molecular Diagnostics Tests & Reagents Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Molecular Diagnostics Tests & Reagents Players by Revenue
  2. 6.1.1 Global Top Molecular Diagnostics Tests & Reagents Players by Revenue (2021-2026)
  3. 6.1.2 Global Molecular Diagnostics Tests & Reagents Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Molecular Diagnostics Tests & Reagents Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Molecular Diagnostics Tests & Reagents Head Office and Area Served
  6. 6.4 Global Molecular Diagnostics Tests & Reagents Players, Product Type & Application
  7. 6.5 Global Molecular Diagnostics Tests & Reagents Manufacturers Established Date
  8. 6.6 Global Molecular Diagnostics Tests & Reagents Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Molecular Diagnostics Tests & Reagents Market Size (2021-2032)
  2. 7.2 North America Molecular Diagnostics Tests & Reagents Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Molecular Diagnostics Tests & Reagents Market Size by Country (2021-2026)
  4. 7.4 North America Molecular Diagnostics Tests & Reagents Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Molecular Diagnostics Tests & Reagents Market Size (2021-2032)
  2. 8.2 Europe Molecular Diagnostics Tests & Reagents Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Molecular Diagnostics Tests & Reagents Market Size by Country (2021-2026)
  4. 8.4 Europe Molecular Diagnostics Tests & Reagents Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Molecular Diagnostics Tests & Reagents Market Size (2021-2032)
  2. 9.2 Asia-Pacific Molecular Diagnostics Tests & Reagents Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Molecular Diagnostics Tests & Reagents Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Molecular Diagnostics Tests & Reagents Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Molecular Diagnostics Tests & Reagents Market Size (2021-2032)
  2. 10.2 South America Molecular Diagnostics Tests & Reagents Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Molecular Diagnostics Tests & Reagents Market Size by Country (2021-2026)
  4. 10.4 South America Molecular Diagnostics Tests & Reagents Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Molecular Diagnostics Tests & Reagents Market Size (2021-2032)
  2. 11.2 Middle East & Africa Molecular Diagnostics Tests & Reagents Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Molecular Diagnostics Tests & Reagents Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Molecular Diagnostics Tests & Reagents Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Abbott Laboratories
  2. 12.1.1 Abbott Laboratories Company Information
  3. 12.1.2 Abbott Laboratories Business Overview
  4. 12.1.3 Abbott Laboratories Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026)
  5. 12.1.4 Abbott Laboratories Molecular Diagnostics Tests & Reagents Product Portfolio
  6. 12.1.5 Abbott Laboratories Recent Developments
  7. 12.2 Shanghai Kehua Bio-engineering
  8. 12.2.1 Shanghai Kehua Bio-engineering Company Information
  9. 12.2.2 Shanghai Kehua Bio-engineering Business Overview
  10. 12.2.3 Shanghai Kehua Bio-engineering Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026)
  11. 12.2.4 Shanghai Kehua Bio-engineering Molecular Diagnostics Tests & Reagents Product Portfolio
  12. 12.2.5 Shanghai Kehua Bio-engineering Recent Developments
  13. 12.3 Johnson and Johnson
  14. 12.3.1 Johnson and Johnson Company Information
  15. 12.3.2 Johnson and Johnson Business Overview
  16. 12.3.3 Johnson and Johnson Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026)
  17. 12.3.4 Johnson and Johnson Molecular Diagnostics Tests & Reagents Product Portfolio
  18. 12.3.5 Johnson and Johnson Recent Developments
  19. 12.4 Merck Millipore
  20. 12.4.1 Merck Millipore Company Information
  21. 12.4.2 Merck Millipore Business Overview
  22. 12.4.3 Merck Millipore Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026)
  23. 12.4.4 Merck Millipore Molecular Diagnostics Tests & Reagents Product Portfolio
  24. 12.4.5 Merck Millipore Recent Developments
  25. 12.5 Beijing Leadman Biochemistry
  26. 12.5.1 Beijing Leadman Biochemistry Company Information
  27. 12.5.2 Beijing Leadman Biochemistry Business Overview
  28. 12.5.3 Beijing Leadman Biochemistry Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026)
  29. 12.5.4 Beijing Leadman Biochemistry Molecular Diagnostics Tests & Reagents Product Portfolio
  30. 12.5.5 Beijing Leadman Biochemistry Recent Developments
  31. 12.6 Thermo Scientific
  32. 12.6.1 Thermo Scientific Company Information
  33. 12.6.2 Thermo Scientific Business Overview
  34. 12.6.3 Thermo Scientific Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026)
  35. 12.6.4 Thermo Scientific Molecular Diagnostics Tests & Reagents Product Portfolio
  36. 12.6.5 Thermo Scientific Recent Developments
  37. 12.7 Sysmex Corporation
  38. 12.7.1 Sysmex Corporation Company Information
  39. 12.7.2 Sysmex Corporation Business Overview
  40. 12.7.3 Sysmex Corporation Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026)
  41. 12.7.4 Sysmex Corporation Molecular Diagnostics Tests & Reagents Product Portfolio
  42. 12.7.5 Sysmex Corporation Recent Developments
  43. 12.8 Siemens Healthcare
  44. 12.8.1 Siemens Healthcare Company Information
  45. 12.8.2 Siemens Healthcare Business Overview
  46. 12.8.3 Siemens Healthcare Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026)
  47. 12.8.4 Siemens Healthcare Molecular Diagnostics Tests & Reagents Product Portfolio
  48. 12.8.5 Siemens Healthcare Recent Developments
  49. 12.9 Roche Diagnostics
  50. 12.9.1 Roche Diagnostics Company Information
  51. 12.9.2 Roche Diagnostics Business Overview
  52. 12.9.3 Roche Diagnostics Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026)
  53. 12.9.4 Roche Diagnostics Molecular Diagnostics Tests & Reagents Product Portfolio
  54. 12.9.5 Roche Diagnostics Recent Developments
  55. 12.10 Ortho Clinical Diagnostics
  56. 12.10.1 Ortho Clinical Diagnostics Company Information
  57. 12.10.2 Ortho Clinical Diagnostics Business Overview
  58. 12.10.3 Ortho Clinical Diagnostics Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026)
  59. 12.10.4 Ortho Clinical Diagnostics Molecular Diagnostics Tests & Reagents Product Portfolio
  60. 12.10.5 Ortho Clinical Diagnostics Recent Developments
  61. 12.11 Mindray
  62. 12.11.1 Mindray Company Information
  63. 12.11.2 Mindray Business Overview
  64. 12.11.3 Mindray Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026)
  65. 12.11.4 Mindray Molecular Diagnostics Tests & Reagents Product Portfolio
  66. 12.11.5 Mindray Recent Developments
  67. 12.12 Danaher Corporation
  68. 12.12.1 Danaher Corporation Company Information
  69. 12.12.2 Danaher Corporation Business Overview
  70. 12.12.3 Danaher Corporation Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026)
  71. 12.12.4 Danaher Corporation Molecular Diagnostics Tests & Reagents Product Portfolio
  72. 12.12.5 Danaher Corporation Recent Developments
  73. 12.13 DAAN Gene
  74. 12.13.1 DAAN Gene Company Information
  75. 12.13.2 DAAN Gene Business Overview
  76. 12.13.3 DAAN Gene Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026)
  77. 12.13.4 DAAN Gene Molecular Diagnostics Tests & Reagents Product Portfolio
  78. 12.13.5 DAAN Gene Recent Developments
  79. 12.14 Cobas
  80. 12.14.1 Cobas Company Information
  81. 12.14.2 Cobas Business Overview
  82. 12.14.3 Cobas Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026)
  83. 12.14.4 Cobas Molecular Diagnostics Tests & Reagents Product Portfolio
  84. 12.14.5 Cobas Recent Developments
  85. 12.15 Caprion
  86. 12.15.1 Caprion Company Information
  87. 12.15.2 Caprion Business Overview
  88. 12.15.3 Caprion Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026)
  89. 12.15.4 Caprion Molecular Diagnostics Tests & Reagents Product Portfolio
  90. 12.15.5 Caprion Recent Developments
  91. 12.16 BioSino Bio-technology
  92. 12.16.1 BioSino Bio-technology Company Information
  93. 12.16.2 BioSino Bio-technology Business Overview
  94. 12.16.3 BioSino Bio-technology Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026)
  95. 12.16.4 BioSino Bio-technology Molecular Diagnostics Tests & Reagents Product Portfolio
  96. 12.16.5 BioSino Bio-technology Recent Developments
  97. 12.17 Bio-Rad Laboratories
  98. 12.17.1 Bio-Rad Laboratories Company Information
  99. 12.17.2 Bio-Rad Laboratories Business Overview
  100. 12.17.3 Bio-Rad Laboratories Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026)
  101. 12.17.4 Bio-Rad Laboratories Molecular Diagnostics Tests & Reagents Product Portfolio
  102. 12.17.5 Bio-Rad Laboratories Recent Developments
  103. 12.18 Biomerieux
  104. 12.18.1 Biomerieux Company Information
  105. 12.18.2 Biomerieux Business Overview
  106. 12.18.3 Biomerieux Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026)
  107. 12.18.4 Biomerieux Molecular Diagnostics Tests & Reagents Product Portfolio
  108. 12.18.5 Biomerieux Recent Developments
  109. 12.19 Becton Dickinson
  110. 12.19.1 Becton Dickinson Company Information
  111. 12.19.2 Becton Dickinson Business Overview
  112. 12.19.3 Becton Dickinson Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026)
  113. 12.19.4 Becton Dickinson Molecular Diagnostics Tests & Reagents Product Portfolio
  114. 12.19.5 Becton Dickinson Recent Developments
  115. 12.20 Beckman Coulter Inc
  116. 12.20.1 Beckman Coulter Inc Company Information
  117. 12.20.2 Beckman Coulter Inc Business Overview
  118. 12.20.3 Beckman Coulter Inc Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026)
  119. 12.20.4 Beckman Coulter Inc Molecular Diagnostics Tests & Reagents Product Portfolio
  120. 12.20.5 Beckman Coulter Inc Recent Developments
  121. 12.21 Aptiv Solution
  122. 12.21.1 Aptiv Solution Company Information
  123. 12.21.2 Aptiv Solution Business Overview
  124. 12.21.3 Aptiv Solution Revenue in Molecular Diagnostics Tests & Reagents Business (2021-2026)
  125. 12.21.4 Aptiv Solution Molecular Diagnostics Tests & Reagents Product Portfolio
  126. 12.21.5 Aptiv Solution Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst